HCW Biologics (HCWB) Receivables (2020 - 2025)
Historic Receivables for HCW Biologics (HCWB) over the last 6 years, with Q3 2025 value amounting to $30667.0.
- HCW Biologics' Receivables fell 9529.53% to $30667.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $30667.0, marking a year-over-year decrease of 9529.53%. This contributed to the annual value of $582201.0 for FY2024, which is 6209.03% down from last year.
- As of Q3 2025, HCW Biologics' Receivables stood at $30667.0, which was down 9529.53% from $21611.0 recorded in Q2 2025.
- HCW Biologics' 5-year Receivables high stood at $1.5 million for Q4 2023, and its period low was $21611.0 during Q2 2025.
- Its 5-year average for Receivables is $448035.2, with a median of $386625.0 in 2022.
- Per our database at Business Quant, HCW Biologics' Receivables skyrocketed by 59386.8% in 2022 and then plummeted by 9670.05% in 2025.
- Quarter analysis of 5 years shows HCW Biologics' Receivables stood at $133000.0 in 2021, then soared by 214.06% to $417695.0 in 2022, then surged by 267.67% to $1.5 million in 2023, then crashed by 62.09% to $582201.0 in 2024, then tumbled by 94.73% to $30667.0 in 2025.
- Its Receivables was $30667.0 in Q3 2025, compared to $21611.0 in Q2 2025 and $87493.0 in Q1 2025.